Agency Agreements in the Pharmaceuticals Industry
136 Contracts & Agreements
- Acer Therapeutics Inc. (1 contract)
- Acreage Holdings, Inc. (1)
- ACURA PHARMACEUTICALS, INC (1)
- Adamis Pharmaceuticals Corp (4)
- ADIAL PHARMACEUTICALS, INC. (3)
- Ampio Pharmaceuticals, Inc. (1)
- APRICUS BIOSCIENCES, INC. (2)
- Aquestive Therapeutics, Inc. (1)
- Aralez Pharmaceuticals Inc. (6)
- ARIAD PHARMACEUTICALS INC (1)
- Assertio Holdings, Inc. (2)
- AUXILIUM PHARMACEUTICALS INC (4)
- AVENUE THERAPEUTICS, INC. (2)
- AYTU BIOSCIENCE, INC (2)
- BIODELIVERY SCIENCES INTERNATIONAL INC (2)
- Biofrontera Inc. (2)
- BioPharmX Corp (1)
- Biostar Pharmaceuticals, Inc. (1)
- BODY & MIND INC. (5)
- Bright Green Corp (1)
- Bristol-Myers Squibb (1)
- Cingulate Inc. (1)
- Citius Pharmaceuticals, Inc. (2)
- Clearside Biomedical, Inc. (1)
- Clever Leaves Holdings Inc. (1)
- CLS Holdings USA, Inc. (2)
- CNS Pharmaceuticals, Inc. (2)
- Cocrystal Pharma, Inc. (1)
- COLLAGENEX PHARMACEUTICALS INC (1)
- ContraVir Pharmaceuticals, Inc. (2)
- CUBIST PHARMACEUTICALS INC (24)
- Elixir Pharmaceuticals, Inc. (1)
- IntelGenx Technologies Corp. (8)
- Iterum Therapeutics plc (2)
- Jaguar Health, Inc. (3)
- JAVELIN PHARMACEUTICALS, INC (1)
- Lexaria Bioscience Corp. (2)
- Lipocine Inc. (2)
- Neuralstem, Inc. (3)
- NovaBay Pharmaceuticals, Inc. (2)
- Onconova Therapeutics, Inc. (1)
- ORAMED PHARMACEUTICALS INC. (2)
- PLx Pharma Inc. (1)
- Quoin Pharmaceuticals, Ltd. (4)
- Sonoma Pharmaceuticals, Inc. (5)
- Stem Holdings, Inc. (1)
- SYNERGY PHARMACEUTICALS, INC. (2)
- Target Group Inc. (1)
- Tenzing Acquisition Corp. (1)
- TITAN PHARMACEUTICALS INC (5)
- Tribute Pharmaceuticals Canada Inc. (2)
- Vallon Pharmaceuticals, Inc. (2)
- Zomedica Pharmaceuticals Corp. (4)
- Placement Agency Agreement (Quoin Pharmaceuticals, Ltd., Filed With SEC on March 8, 2024)
- Placement Agency Agreement, dated February 19, 2024, by and between Biofrontera Inc. and Roth Capital Partners, LLC (Biofrontera Inc., Filed With SEC on February 23, 2024)
- Selling Agency Agreement, dated February 14, 2024, between IntelGenx Technologies Corp. and Digital Offering, LLC (IntelGenx Technologies Corp., Filed With SEC on February 20, 2024)
- Form of Placement Agency Agreement (Quoin Pharmaceuticals, Ltd., Filed With SEC on February 13, 2024)
- Placement Agency Agreement, dated February 6, 2024 by and among Clearside Biomedical, Inc. and Citizens JMP Securities, LLC (Clearside Biomedical, Inc., Filed With SEC on February 8, 2024)
- Placement Agency Agreement, dated as of February 1, 2024, by and between GRI Bio, Inc. and A.G.P./Alliance Global Partners (Vallon Pharmaceuticals, Inc., Filed With SEC on February 2, 2024)
- ADAMIS PHARMACEUTICALSCORPORATION and EQUINITI TRUST COMPANY,LLC, as Warrant Agent WarrantAgency Agreement Dated as of August 4, 2023 WARRANT AGENCY AGREEMENT (Adamis Pharmaceuticals Corp, Filed With SEC on November 14, 2023)
- Placement Agency Agreement, dated October 30, 2023, by and between Biofrontera Inc. and Roth Capital Partners, LLC (Biofrontera Inc., Filed With SEC on November 2, 2023)
- Placement Agency Agreement dated October 31, 2023, by and among Avenue Therapeutics, Inc., Maxim Group LLC and Lake Street Capital Markets, LLC (AVENUE THERAPEUTICS, INC., Filed With SEC on November 2, 2023)
- Form of Placement Agency Agreement (AVENUE THERAPEUTICS, INC., Filed With SEC on October 24, 2023)
- Form of Placement Agency Agreement (Sonoma Pharmaceuticals, Inc., Filed With SEC on October 13, 2023)
- Placement Agency Agreement by and between the Company and the Placement Agent entered into on September 28, 2023 (Lexaria Bioscience Corp., Filed With SEC on October 3, 2023)
- Consent Agreement by and among Body and Mind Inc., DEP Nevada, Inc., NMG OH P1, LLC, FG Agency Lending, LLC and Bomind Holdings LLC, dated September 11, 2023 (BODY & MIND INC., Filed With SEC on September 12, 2023)
- Form of Placement Agency Agreement (Neuralstem, Inc., Filed With SEC on September 11, 2023)
- Placement Agency Agreement (Adamis Pharmaceuticals Corp, Filed With SEC on August 3, 2023)
- Consent Agreement by and among Body and Mind Inc., DEP Nevada, Inc., NMG OH 1, LLC, FG Agency Lending LLC and Bomind Holdings LLC, dated July 21, 2023 (BODY & MIND INC., Filed With SEC on July 26, 2023)
- Form of Placement Agency Agreement (AYTU BIOSCIENCE, INC, Filed With SEC on June 5, 2023)
- Placement Agency Agreement dated May 21, 2023 by and between the Company and EF Hutton, division of Benchmark Investments, LLC (Bright Green Corp, Filed With SEC on May 24, 2023)
- Placement Agency Agreement (Lexaria Bioscience Corp., Filed With SEC on May 10, 2023)
- Form of Placement Agency Agreement (Neuralstem, Inc., Filed With SEC on April 5, 2023)
- Form of Placement Agency Agreement (Cingulate Inc., Filed With SEC on March 10, 2023)
- Placement Agency Agreement by and between the Placement Agent and the Company (Quoin Pharmaceuticals, Ltd., Filed With SEC on February 28, 2023)
- Placement Agency Agreement (ADIAL PHARMACEUTICALS, INC., Filed With SEC on February 24, 2023)
- Form of Placement Agency Agreement (Quoin Pharmaceuticals, Ltd., Filed With SEC on February 3, 2023)
- Form of Placement Agency Agreement (CNS Pharmaceuticals, Inc., Filed With SEC on December 1, 2022)
- Form of Placement Agency Agreement (CNS Pharmaceuticals, Inc., Filed With SEC on November 15, 2022)
- Placement Agency Agreement, dated September 6, 2022, by and between the Company and the Placement Agent (Tenzing Acquisition Corp., Filed With SEC on September 7, 2022)
- Placement Agency Agreement dated June 6, 2022, between Aquestive Therapeutics, Inc. and A.G.P./Alliance Global Partners (Aquestive Therapeutics, Inc., Filed With SEC on June 8, 2022)
- Placement Agency Agreement, dated May 13, 2022, between the Company and Ladenburg Thalmann & Co., Inc (Vallon Pharmaceuticals, Inc., Filed With SEC on May 13, 2022)
- Placement Agency Agreement, dated May 6, 2022, by and between the Company and Ladenburg Thalmann & Co. Inc (Neuralstem, Inc., Filed With SEC on May 6, 2022)
- Placement Agency Agreement (ADIAL PHARMACEUTICALS, INC., Filed With SEC on February 14, 2022)
- Placement Agency Agreement (TITAN PHARMACEUTICALS INC, Filed With SEC on February 3, 2022)
- Omnibus Collateral Assignment between Body and Mind Inc., DEP Nevada Inc., Nevada Medical Group, LLC, NMG MI 1, Inc., NMG MI C1, Inc., NMG MI P1, Inc., and FG Agency Lending LLC,... (BODY & MIND INC., Filed With SEC on July 23, 2021)
- Pledge Agreement between Body and Mind Inc., DEP Nevada Inc., Nevada Medical Group, LLC, and FG Agency Lending LLC, dated July 19, 2021 (BODY & MIND INC., Filed With SEC on July 23, 2021)
- Placement Agency Agreement, dated April 29, 2021, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc (Jaguar Health, Inc., Filed With SEC on April 30, 2021)
- Placement Agency Agreement by and between the Company and Roth Capital Partners, LLC, dated as of February 10, 2021 (Assertio Holdings, Inc., Filed With SEC on February 12, 2021)
- Placement Agency Agreement by and between the Company and Roth Capital Partners, LLC, dated as of February 5, 2021 (Assertio Holdings, Inc., Filed With SEC on February 9, 2021)
- Placement Agency Agreement (TITAN PHARMACEUTICALS INC, Filed With SEC on January 19, 2021)
- Placement Agency Agreement, dated January 13, 2021, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc (Jaguar Health, Inc., Filed With SEC on January 14, 2021)
- Collateral Agency Accession, dated as of December 18, 2020 (Clever Leaves Holdings Inc., Filed With SEC on December 28, 2020)